Tumor immunotherapy has transformed neoplastic disease management, yet low response
rates and immune complications persist as major challenges. Extracellular vesicles …

Lung cancer remains the leading cause of cancer-related deaths globally, and the survival
rate remains low despite advances in diagnosis and treatment. The progression of lung …

Background Liver metastasis (LM) is a major obstacle to the prognosis of gastric cancer
(GC) patients, but the molecular mechanism underlying gastric cancer liver metastasis (GC …

Lung cancer is a commonly diagnosed disease worldwide, with non‐small cell lung cancers
(NSCLCs) accounting for≈ 85% of cases. Cigarette smoke is an environmental exposure …

Liver metastasis is one of the major causes of colorectal cancer (CRC)-related morbidity and
mortality. Delivering small interfering RNAs (siRNAs) or noncoding RNAs has been reported …

Abstract Background Cancer-associated fibroblasts (CAFs), one of the major components of
the tumor stroma, contribute to an immunosuppressive tumor microenvironment (TME) …

Today, adoptive cell therapy has many successes in cancer therapy, and this subject is
brilliant in using chimeric antigen receptor T cells. The CAR T cell therapy, with its FDA …

Non‐coding RNAs (ncRNAs) have attracted extensive attention due to their vital roles in
tumorigenesis and progression, especially in the immunotherapy resistance. Tumor …

Background Predictive biomarkers for oesophageal squamous cell carcinoma (ESCC)
immunotherapy are lacking, and immunotherapy resistance remains to be addressed. The …

Despite continuous improvements in research and new cancer therapeutics, the goal of
eradicating cancer remains elusive because of drug resistance. For a long time, drug …